Quickly
Socially
Trending
Crypto
The approval for emergency use authorisation for Covaxin, COVID-19 vaccine developed by Bharat Biotech, has been requested by it's partner firm Ocugen in the US for children below the age of 18 years.
Bharat Biotech's US partner Ocugen announced that it had asked authorities for emergency use authorization for Covid-19 vaccine Covaxin in US, for children below 18
— ANI (@ANI) November 6, 2021
Dr Raches Ella, Bharat Biotech's Clinical Lead for COVID-19 Vaccines, Tweeted the Development:
"We are pleased to announce our EUA filing to the US-FDA through our partners- Ocugen," Bharat Biotech's clinical lead for Covid-19 vaccines, Dr Raches Ella tweeted.
— ANI (@ANI) November 6, 2021
(SocialLY brings you all the latest breaking news, viral trends and information from social media world, including Twitter (X), Instagram and Youtube. The above post is embeded directly from the user's social media account and LatestLY Staff may not have modified or edited the content body. The views and facts appearing in the social media post do not reflect the opinions of LatestLY, also LatestLY does not assume any responsibility or liability for the same.)
Google Trends
